Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen to Supply siRNA to Novartis

NEW YORK, Aug. 4 (GenomeWeb News) - Qiagen said today that it has entered an agreement to supply a genome-wide siRNA library to Novartis.


Financial terms of the agreement were not disclosed.


Qiagen uses a proprietary chemistry it picked up in its April, 2002, acquisition of Xeragon to synthesize siRNA molecules.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.